McKesson : New MYLUNG Consortium Research Demonstrates Remote Pharmacist Intervention Significantly Increases Clinical Trial Enrollments in Community Oncology Setting

Average monthly enrollment nearly doubled with pharmacy intervention


Remote pharmacist easily adapted into clinic workflows in community... | June 6, 2022

Related Keywords

New York ,United States ,Rocky Mountain ,Texas ,Minnesota ,Illinois ,Virginia ,Maryland ,American ,Elizabeth Koselke ,Robertl Coleman ,Claire Crye ,Nicholas Robert ,Eli Lilly ,Amgen ,American Society Of Clinical Oncology ,Mckesson Corporation ,Astrazeneca ,Virginia Oncology Associates ,Part Of Mckesson Corporation ,Willamette Valley Cancer Institute ,Consortium Principal Investigator ,Research Center ,Mountain Cancer Centers ,Mirati Therapeutics Inc ,Mckesson ,Foundation For Lung Cancer ,Roche Group ,Southern Cancer Center ,Us Oncology Research ,Consortium Protocol ,Us Oncology Network ,Clinical Oncology ,African American ,Mirati Therapeutics ,Lung Cancer ,Illinois Cancer Specialists ,Maryland Oncology Hematology ,Minnesota Oncology ,New York Oncology Hematology ,Oncology Hematology Care ,Rocky Mountain Cancer Centers ,Texas Oncology ,Virginia Cancer Specialists ,Woodlands Medical ,Mckesson Corporation Stock Exchange ,News ,Information ,Press Release ,Average ,Onthly ,Enrollment ,Early ,Oubled ,Ith ,Pharmacy ,Remote ,Pharmacist ,Easily ,Adapted ,Into ,Clinic ,Workflows ,N Mck Us58155q1031 ,